40772 Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 

Therefore, you should always check the 

Agency’s Web site at https://

www.fda.gov/AdvisoryCommittees/ 

default.htm and scroll down to the 

appropriate advisory committee meeting 

link, or call the advisory committee 

information line to learn about possible 

modifications before coming to the 

meeting. 

SUPPLEMENTARY INFORMATION: 

Agenda: The committee will discuss 

appropriate patient selection criteria 

and clinical trial design features, 

including acceptable endpoints, for 

demonstrating clinical benefit for drugs 

intended to treat interstitial cystitis and 

bladder pain syndrome. The committee 

will also discuss whether bladder pain 

syndrome and interstitial cystitis reflect 

overlapping or different populations, 

and whether it is appropriate to assess 

efficacy in the same way for both 

conditions. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at https://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee meeting 

link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. All electronic and 

written submissions submitted to the 

docket (see ADDRESSES) on or before 

November 22, 2017, will be provided to 

the committee. Oral presentations from 

the public will be scheduled between 

approximately 1 p.m. and 2 p.m. Those 

individuals interested in making formal 

oral presentations should notify the 

contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before November 14, 2017. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

FDA may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

November 15, 2017. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with disabilities. 

If you require special accommodations 

due to a disability, please contact 

Kalyani Bhatt at least 7 days in advance 

of the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

https://www.fda.gov/ 

AdvisoryCommittees/ 

AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: August 22, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–18131 Filed 8–25–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Committee on Rural Health and Human 

Services 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice of Meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, notice 

is hereby given of a National Advisory 

Committee on Rural Health and Human 

Services (NACRHHS) meeting. The 

meeting will be open to the public. 

Informaton about the NACRHHS 

meeting can be obtained by accessing 

the following Web site: http://

www.hrsa.gov/advisorycommittees/ 

rural/. 

DATES: The meeting will be held on 

September 11, 2017, 8:45 a.m. to 5:00 

p.m. MDT; September 12, 2017, 8:30 

a.m. to 5:15 p.m. MDT; and September 

13, 2017, 8:30 a.m. to 11:00 a.m. MDT. 

ADDRESSES: This meeting will be held at 

the Spring Hill Suites located at 424 E. 

Parkcenter Blvd., Boise, Idaho 83706, 

(208) 342–1044. 

FOR FURTHER INFORMATION CONTACT: 

Steve Hirsch, MSLS, Administrative 

Coordinator, National Advisory 

Committee on Rural Health and Human 

Services, Health Resources and Services 

Administration, Parklawn Building, 

17W29C, 5600 Fishers Lane, Rockville, 

MD 20857, Telephone (301) 443–0835, 

Fax (301) 443–2803. 

SUPPLEMENTARY INFORMATION: 

NACRHHS provides counsel and 

recommendations to the Secretary with 

respect to the delivery, research, 

development, and administration of 

health and human services in rural 

areas. 

The meeting on Monday, September 

11, will be called to order at 8:45 a.m. 

by the Chairperson of the Committee, 

The Honorable Ronnie Musgrove. The 

Committee will examine the issue of 

suicide in rural areas and the issue of 

Rural Health Clinic Modernization. The 

day will conclude with a period of 

public comment at approximately 5:15 

p.m. 

The Committee will break into 

Subcommittees and depart for site visits 

Tuesday morning, September 12, at 

approximately 8:15 a.m. Subcommittees 

will visit First Baptist Church, 126 S. 

Hayes Avenue in Emmett, Idaho and the 

North Canyon Medical Center, 267 N. 

Canyon Drive in Gooding, Idaho. The 

day will conclude at the Spring Hill 

Suites with a period of public comment 

at approximately 5:00 p.m. 

The Committee will meet to 

summarize key findings and develop a 

work plan for the next quarter and the 

following meeting on Wednesday 

morning, September 13, at 8:30 a.m. 

Persons interested in attending any 

portion of the meeting should contact 

Alfred Delena at the Federal Office of 

Rural Health Policy (FORHP) via 

telephone at (301) 443–3388 or by email 

at ADelena@hrsa.gov. The Committee 

meeting agenda will be posted on the 

Committee’s Web site at http://

www.hrsa.gov/advisorycommittees/ 

rural/. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2017–18139 Filed 8–25–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Notice of Intent To Establish the Pain 

Management Best Practices InterAgency Task Force and Request for 

Nominations for Task Force Members 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 


asabaliauskas on DSKBBXCHB2PROD with NOTICES